As a host of generics circle the gates, Novartis has lost another bid to waylay MSN Pharmaceuticals’ copycat of the Swiss ...

The prevalence of PH was 12.8% in those hospitalized in 2018 with left heart disease, a lower percentage than found in previous research.

Among cardiovascular deaths, sudden death and heart failure death are the leading cardiac modes of death in HFPEF clinical trials. Compared with HFREF, the proportions of cardiovascular deaths ...

Global Commercial Launch Preparations Underway for First Potential Approval Towards Building Specialty Cardiovascular Franchise Company Recently Launched Unbranded Disease Awareness Campaign “HCM ...

Recent pre-clinical studies in mice show that glucagon blockers can improve heart function in HFpEF, a type of heart failure.

The use of mineralocorticoid receptor antagonists (MRAs) has been well established for patients with heart failure and reduced ejection fraction (HFrEF). However, the application of MRAs in patients ...

Jason Butler, an analyst from JMP Securities, reiterated the Buy rating on Cytokinetics (CYTK – Research Report). The associated price ...

Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ...

[52] The presence of CAD was associated with greater reduction of LVEF in HFPEF, and, conversely, the absence of CAD was associated with a greater improvement of LVEF in HFREF.

Catheter ablation is associated with significant reductions in AF symptoms, AF-related hospitalization, and HF symptoms across HF subtypes.